Genomic Profiling with MammaPrint® + BluePrint® Identifies Aggressive Tumor Subtypes Driving Racial Survival Disparities in HR+/HER2– Early-Stage Breast Cancer

Study of over 1000 females with breast cancer finds that genomic risk and molecular subtype, and not race, drives ...
ascopubs.org

Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance High-grade neuroendocrine carcinoma ...
ascopubs.org

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer

Adjuvant radiotherapy (RT) is used for women with early-stage invasive breast cancer treated with breast-conserving surgery. However, some women with low risk of recurrence may safely be spared RT.
Mayo Clinic

Comparative gene expression studies in Alzheimer's disease and other conditions

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

Agendia, Inc.: Genomic Profiling with MammaPrint + BluePrint Identifies Aggressive Tumor Subtypes Driving Racial Survival Disparities in HR+/HER2- Early-Stage Breast Cancer

Multicenter study of over 1000 females with breast cancer, published in npj Breast Cancer, finds that genomic risk and molecular subtype, and not race, drives differential survival outcomes Agendia ...